Findings

What do systematic reviews say?

3 questions · 6 findings · 4 reviews · asked by two or more reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 4 · 66.7%Moderate 2 · 33.3%High 0 · 0%

Short‐acting insulin analogues vs regular human insulin

HbA1c (%)

2 findings from 2 reviews · compare the 2 reviews

Short‐acting insulin analogues versus regular human insulin for adult, non‐pregnant persons with type 2 diabetes… 2018 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 2608 participants
Low
Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus 2016 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 2608 participants
Low

Summary of findings: insulin detemir vs NPH insulin

HbA1c (%)

2 findings from 2 reviews · compare the 2 reviews

(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
no estimate extracted
8 studies · 3122 participants
Moderate
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes… 2020 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 2233 participants
Low

Insulin glargine vs NPH insulin

HbA1c (%)

2 findings from 2 reviews · compare the 2 reviews

(Ultra‐)long‐acting insulin analogues for people with type 1 diabetes mellitus 2021 · Cochrane Headline outcomes only
no estimate extracted
9 studies · 2285 participants
Moderate
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes… 2020 · Cochrane Headline outcomes only
no estimate extracted
16 studies · 5809 participants
Low